SLC4A7 and breast carcinoma: The high NBCn1 TOR value of ~15,000 s−1 (Supplementary Table 3), provides breast cancer cells with an additional survival advantage in that mediating a given rate of cellular base influx theoretically would require fewer plasma membrane NBCn1 transporters, thereby lowering the energy expenditure utilized in the processes of transporter synthesis and degradation.